Phase IIb, comparative, multicenter, randomized, double-blind study to evaluate the efficacy and safety of intravenous VIS410 administered together with oseltamivir (tamiflu) compared with oseltamivir as monotherapy in hospitalized adults with influenza A virus infection. that require oxygen support
COMMERCIAL CLINICAL TRIAL
Clinical trial information
- Developer: VISTERRA INC.
- Phase: II
- Execution start: 21/12/2017
- End of execution: 30/10/2019
- IP: JOSE HERNANDEZ QUERO